Principal Investigators


    Contact information of lead PI


    European Commission

    Title of project or programme

    European Prevention of Alzheimer’s Dementia Consortium (EPAD)

    Source of funding information

    European Commission FP7-IMI-Seventh Framework Programme/Innovative Medicines Initiative

    Total sum awarded (Euro)

    € 25,880,000

    Start date of award


    Total duration of award in years


    The project/programme is most relevant to:

    Alzheimer's disease & other dementias


    Research Abstract

    There is an urgent need for new treatments for Alzheimer’s disease. The number of people affected worldwide is expected to reach over 100 million by 2050, yet despite intensive efforts over many years, there is still no cure for Alzheimer’s and little in the way of treatments. Today, research increasingly focuses on ways to prevent the onset of Alzheimer’s in the first place. The EPAD project is pioneering a novel, more flexible approach to clinical trials of drugs designed to prevent Alzheimer’s dementia. Using an ‘adaptive’ trial design should deliver better results faster and at lower cost.

    Lay Summary

    Further information available at:

Types: Investments > €500k
Member States: European Commission
Diseases: Alzheimer's disease & other dementias
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF